1274 (1274) Fair Value & Analysis

Consumer Cyclical · Market cap HK$908M

1 1274 1274 · HK

PriceHK$3.68

Fair ValueHK$0.7200

Upside-80.4%

Quality17/100

Evidence: Low Range HK$0.4800 – HK$0.9000

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price −14.4% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$3.04 – HK$17.46 · fair‑value band HK$0.4800 – HK$0.9000 · the HK$3.68 price screens above the HK$0.7200 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1274 (1274) currently trades at HK$3.68, while our model-based Fair Value estimate is HK$0.7200 — implying the stock looks roughly 80.4% overvalued today. We read business quality at 17/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 1274 generated revenue of HK$1.0B at a net margin of -41.6%. Revenue grew 3.8% year over year. It earns a return on equity of -47.0%. Net debt stands at HK$243M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$1.0B

Revenue growth (YoY) +3.8%

Net margin -41.6%

Return on equity -47.0%

Free cash flow −HK$408M FY2026

Operating margin -36.1%

More key figures

EPS (TTM) HK$-0.7500

Net debt HK$243M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

1274 reported revenue of HK$1.1B in FY2026 versus HK$219M in FY2022, a compound +50.2%/yr. Reported net income was −HK$451M in FY2026.

Revenue +50.2%/yr

FY22 HK$219M

FY23 HK$1.5B

FY24 HK$1.3B

FY25 HK$1.3B

FY26 HK$1.1B

Net income

FY22 −HK$559M

FY23 −HK$398M

FY24 −HK$216M

FY25 −HK$288M

FY26 −HK$451M

Is 1274 fairly valued? → Check now

Similar stocks

6 more Auto Parts stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
O'Reilly Automotive, Inc ORLY34	R$1.49	R$0.4900	-67%
AutoZone, Inc AZOI34	R$73.14	R$10.17	-86%
Hyundai Mobis Co 012330	570,000 KRW	591,992 KRW	+4%
Fuyao Glass Industry Group 600660	¥50.05	¥111.37	+123%
Magna International Inc MGAN	1,182 MXN	1,064 MXN	-10%
Ningbo Tuopu Group 601689	¥63.21	¥19.12	-70%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1274 (1274) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.7200 versus a price of HK$3.68 — about −80% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1274?

Our model-based fair value for 1274 is HK$0.7200 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$3.68.

What is the quality score of 1274?

1274 has a Quality Score of 17/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1274 (1274)?

1274 reported trailing-twelve-month revenue of about HK$1.0B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1274?

The net profit margin of 1274 is about -41.6%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.